Times of India
US pharma giant is unhappy with Germany; CEO calls planned healthcare reform ‘terrible’
US drug maker Eli Lilly is cutting its investment in a German factory by half. This decision follows new healthcare cost-cutting laws in Germany. The company CEO called the reforms a bad signal for the industry. This move impacts Germany's…
View original source — Times of India ↗
Related stories
AllAfrica
WorldJun 18, 2026 · 1 min
Africa: Tanzania Targets Africa Pharma Manufacturing Hub Status
AllAfrica
The Hill
HealthJun 16, 2026 · 1 min
The wrong prescription for drug affordability
The Hill
Japan Times
BusinessJun 18, 2026 · 1 min
U.K. in advanced talks with Nissan over Sunderland plant support, sources say
Japan Times
Bloomberg
BusinessJun 5, 2026 · 1 min
AstraZeneca Broadens US Growth Push
Bloomberg